Sign in

CIK 0002104204 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Alamar Biosciences, Inc.

Sign in to watch
Ticker
ALMR
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364899036
Phone
510-626-9888
Business address
47071 BAYSIDE PARKWAY, FREMONT, CA, 94538
  1. 4 Open-market sale 10% owner sold 111,313 shares at $29.89 ($3,327,146)
  2. 4 Open-market sale 10% owner sold 187,636 shares at an average $30.25 ($5,676,413)
  3. 4 Open-market sale 10% owner sold 185,731 shares at an average $32.14 ($5,968,888)
  4. 4 Open-market sale 10% owner sold 280,458 shares at an average $30.56 ($8,569,760)
  5. 4 Open-market sale 10% owner sold 342,626 shares at an average $29.93 ($10,253,095)
  6. 4 Open-market sale 10% owner sold 217,512 shares at an average $27.35 ($5,949,983)
  7. 4 Open-market sale 10% owner sold 173,673 shares at an average $27.73 ($4,816,121)
  8. 4 Grant or award General Counsel acquired 29,000 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Grant or award Director acquired 5,686 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Conversion 10% owner acquired 10,594,547 shares (conversion)
  13. 4 Open-market buy 10% owner bought 235,294 shares at $17.00 ($3,999,998)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award President acquired 37,220 shares (grant or award)
  17. 4 Grant or award Chief Operating Officer acquired 37,220 shares (grant or award)
  18. 4 Grant or award Chief Executive Officer acquired 76,509 shares (grant or award)
  19. 4 Grant or award Chief Financial Officer acquired 37,220 shares (grant or award)
  20. 4 Open-market buy Director bought 235,294 shares at $17.00 ($3,999,998)

Page 1 of 2 · 30 filings